Tert-butyl 1'-(4-bromophenyl)-6-hydroxy-2'-oxospiro[3H-indole-2,3'-pyrrolidine]-1-carboxylate;methanol
C23H27BrN2O5 — CID 145438950
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 1'-(4-bromophenyl)-6-hydroxy-2'-oxospiro[3H-indole-2,3'-pyrrolidine]-1-carboxylate;methanol
Tert-butyl 1'-(4-bromophenyl)-6-hydroxy-2'-oxospiro[3H-indole-2,3'-pyrrolidine]-1-carboxylate;methanol (PubChem CID 145438950) has the molecular formula C23H27BrN2O5 and a molecular weight of 491.38 g/mol. Its IUPAC name is tert-butyl 1'-(4-bromophenyl)-6-hydroxy-2'-oxospiro[3H-indole-2,3'-pyrrolidine]-1-carboxylate;methanol.
Molecular Properties
| Compound Name | Tert-butyl 1'-(4-bromophenyl)-6-hydroxy-2'-oxospiro[3H-indole-2,3'-pyrrolidine]-1-carboxylate;methanol |
|---|---|
| PubChem CID | 145438950 |
| Molecular Formula | C23H27BrN2O5 |
| Molecular Weight | 491.38 g/mol |
| Exact Mass | 490.11 |
| IUPAC Name | tert-butyl 1'-(4-bromophenyl)-6-hydroxy-2'-oxospiro[3H-indole-2,3'-pyrrolidine]-1-carboxylate;methanol |
| SMILES | CC(C)(C)OC(=O)N1c2cc(O)ccc2CC12CCN(c1ccc(Br)cc1)C2=O.CO |
| InChI | InChI=1S/C22H23BrN2O4.CH4O/c1-21(2,3)29-20(28)25-18-12-17(26)9-4-14(18)13-22(25)10-11-24(19(22)27)16-7-5-15(23)6-8-16;1-2/h4-9,12,26H,10-11,13H2,1-3H3;2H,1H3 |
| InChIKey | LJQJFSCCIVMMGB-UHFFFAOYSA-N |
| XLogP | 4.24 |
| TPSA | 90.31 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 491.38 |
| LogP ≤ 5 | 4.24 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 145438950 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.